CONTACT US
Back to Resources
Back to Resources

Securing & Maintaining Access & Reimbursement for Rare Disease Therapies

Apr 8, 2025

Join Molly Borchardt, PharmD, and Erin Lopata, PharmD, MPH, from the Precision Access Experience Team, as they unveil crucial insights that can help enhance your access strategy.

Rare diseases, impacting fewer than 200,000 individuals in the US, present daunting access and reimbursement obstacles, with 95% lacking approved therapy. As the median treatment cost exceeds $200,000 annually, concerns about affordability, access, and value persist for over 10,000 identified rare diseases, affecting 30 million Americans.

Download White Paper
GettyImages-1214485186-Hand_with_Vial_Closeup-RET

What you'll learn:

  • Strategies for navigating the complexities of rare disease management
  • Guidance on engaging with payers early to ensure optimal access
  • Tips for demonstrating the holistic value of your rare disease innovation

Get the insights to sharpen your rare disease therapy's market access strategy.